Pyrimethamine as primary prophylaxis of toxoplasmic encephalitis in patients infected with human immunodeficiency virus: open study.
C
C
Bachmeyer
I
I
Gorin
J
J
Deleuze
J P
JP
Morini
J P
JP
Escande
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D015331:Cohort Studies; D004361:Drug Tolerance; D006801:Humans; D011739:Pyrimethamine / Q000009:adverse effects / Q000494:pharmacology*; D014122:Toxoplasma / Q000276:immunology; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000276:immunology / Q000517:prevention & control*
D000913:Antibodies, Protozoan; D011739:Pyrimethamine